NasdaqGM - Delayed Quote USD

Drugs Made In America Acquisition Corp. (DMAA)

10.89 +0.01 (+0.09%)

At close: November 6 at 4:00:00 PM EST

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Name	Title	Pay	Exercised	Year Born
Mr. Roger Bendelac	Chief Executive Officer	--	--	1957
Mr. Saleem Elmasri C.P.A.	CFO & Principal Accounting Officer	--	--	1986

420 Lexington Avenue

Suite 1402

New York, NY 10170

United States

646 726 7074

Sector:: Financial Services
Industry:

Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York.

Drugs Made In America Acquisition Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events Information Not Available

October 21, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

See Full Filing

September 14, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

See Full Filing

August 14, 2026 at 12:00 AM UTC

10-Q: Periodic Financial Reports

See Full Filing

July 20, 2026 at 12:00 AM UTC

425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions